Last reviewed · How we verify

NCT06697717

End-expiratory Transpulmonary Pressure-guided vs Electrical Impedance Tomography-guided PEEP Titration Methods in Patients With Intra-abdominal Hypertension Combined With Acute Respiratory Distress Syndrome: a Randomized Crossover Controlled Study

Recruiting now NA Last updated 21 November 2025
What this trial tests

NA trial testing Transpulmonary Pressure-Guided PEEP Titration in IAH and ARDS Patients in Intra-abdominal Hypertension in 20 participants. Currently enrolling.

Timeline
1 January 2025
Primary endpoint
1 March 2026
1 March 2026

Quick facts

Lead sponsorXiaoJing Zou,MD
PhaseNA
StatusRecruiting now
Study typeINTERVENTIONAL
Allocationrandomized
Designcrossover
Maskingsingle
Primary purposesupportive care
Enrollment20
Start date1 January 2025
Primary completion1 March 2026
Estimated completion1 March 2026
Sites1 location across China

Drugs / interventions tested

Conditions studied

Sponsor

XiaoJing Zou,MD

Who can join

Adults 18 to 80, any sex, with Intra-abdominal Hypertension or Acute Respiratory Distress Syndrome (ARDS). Patients with the condition only — healthy volunteers not accepted.

Sponsor's own description

This study aims to adopt a randomized crossover design to compare the effects of end-expiratory transpulmonary pressure-guided PEEP titration and EIT-guided PEEP titration on local lung ventilation, shunt, dead space, and ventilation-perfusion (V/Q) ratio as monitored by EIT. Additionally, it will evaluate their impact on respiratory mechanics, chest wall mechanics, mechanical power, hemodynamics, gas exchange, intra-abdominal pressure, abdominal perfusion pressure, and renal perfusion. By identifying an optimal PEEP titration strategy for patients with intra-abdominal hypertension (IAH) and acute respiratory distress syndrome (ARDS), this study aims to develop a mechanical ventilation approach that maintains lung recruitment and minimizes lung injury while avoiding adverse effects on other organs. The findings could facilitate the clinical application of this strategy and benefit a broader population of patients with IAH and ARDS.

Publications & conference data

No peer-reviewed publications indexed yet for this trial.

Verify or expand the search:

Other XiaoJing Zou,MD trials

Trials by the same sponsor.

Verify against primary sources

Data sources for this page

Drug Landscape aggregates and links these public records for informational use only. Always verify against the primary source before clinical or regulatory decisions. Canonical URL: https://druglandscape.com/trial/NCT06697717.

Primary sources · FDA · ClinicalTrials.gov · EMA · SEC EDGAR · ChEMBL · Wikidata · full sourcing